The Prognostic Role of Tricuspid Annular Plane Systolic Excursion in Critically Ill Patients With Septic Shock

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06008067

Enrollment

100

Registered

2023-08-23

Start date

2023-04-01

Completion date

2023-07-01

Last updated

2023-08-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Septic Shock

Keywords

Critical Care, Septic Shock, Echocardiography, RV dysfunction

Brief summary

The aim of this study is to evaluate the possible prognostic performance of RV dysfunction, as assessed by TAPSE, in non-cardiac patients with septic shock.

Detailed description

The objective is to investigate the prognostic performance of right ventricular dysfunction, as assessed by tricuspid annular plane systolic excursion (TAPSE), in non-cardiac patients with septic shock.

Interventions

RADIATIONtricuspid annular plane systolic excursion (TAPSE)

Echocardiography

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 64 Years

Inclusion criteria

* Adult patients (18 - 64 years old) with septic shock after admission according to 2016 consensus definition (Sepsis-3).

Exclusion criteria

* Pregnant females * Trauma * Documented coronary heart disease * History of myocardial infarction * Myocarditis * Thrombo-embolic pulmonary disease * Valvular heart disease * Corpulmonale * Arrhythmia * Known left ventricular ejection fraction \< 40% * Poor echocardiographic window

Design outcomes

Primary

Measure	Time frame	Description
28-day mortality	Day 28	Mortality rate after at day 28.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026